CHCWM – Cancer & Hematology Centers of West Michigan

AstraZeneca D8151C00001

 

    • A Phase II Study to Evaluate the Safety, Pharmacokinetics, and Clinical Activity of AZD0171 in Combination with Durvalumab and Chemotherapy in Participants with Locally Advanced or Metastatic Solid Tumours
    • PI: Dr. Chandana
    • Available at: CHCWM – Muskegon, Holland Cancer Center, Lacks Cancer Center at Saint Mary’s, Lemmen-Holton Cancer Pavilion

For more information on this trial, read its profile on clinicaltrials.gov